1. Home
  2. JBDI vs GDTC Comparison

JBDI vs GDTC Comparison

Compare JBDI & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JBDI Holdings Limited Ordinary Shares

JBDI

JBDI Holdings Limited Ordinary Shares

HOLD

Current Price

$1.04

Market Cap

13.7M

Sector

N/A

ML Signal

HOLD

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$1.09

Market Cap

15.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JBDI
GDTC
Founded
1983
2018
Country
Singapore
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.7M
15.5M
IPO Year
2024
2023

Fundamental Metrics

Financial Performance
Metric
JBDI
GDTC
Price
$1.04
$1.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.1M
1.3M
Earning Date
01-01-0001
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,445,000.00
$573,193.00
Revenue This Year
N/A
$5.37
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
63.03
52 Week Low
$0.49
$0.73
52 Week High
$3.00
$3.68

Technical Indicators

Market Signals
Indicator
JBDI
GDTC
Relative Strength Index (RSI) 68.64 53.16
Support Level $0.52 $0.80
Resistance Level $1.35 $0.90
Average True Range (ATR) 0.14 0.13
MACD 0.05 0.03
Stochastic Oscillator 59.63 81.79

Price Performance

Historical Comparison
JBDI
GDTC

About JBDI JBDI Holdings Limited Ordinary Shares

JBDI Holdings Ltd is a supplier of Reconditioned and new Containers in Singapore. It's in the trading of reconditioned and recycling containers in Singapore and the Southeast Asia region. The company offers reconditioning and recycling drums, including open top drums, metal drums, plastic drums, plastic carboys, and intermediate bulk containers, as well as new drums, and collects waste drums and related products. It serves solvent, chemical, petroleum, and edible product oil industries.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: